Copper-mediated radiosynthesis of [18F]rucaparib
<p>The poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib is used in the clinic to treat <em>BRCA</em>-mutated cancers. Herein, we report two strategies to access the <sup>18</sup>F-isotopologue of rucaparib by applying a copper-mediated nucleophil...
| Autors principals: | , , , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
American Chemical Society
2021
|